John P. Brancaccio

Director, TAMIR BIOTECHNOLOGY, INC.

Companies

OKYO Pharma LtdBoard member May 16, 2022 to now¹
Hepion Pharmaceuticals, Inc.Chair Feb 21, 2024 to Feb 21, 2024²
Cardiff Oncology, Inc.Board member Jan 23, 2012 to Mar 10, 2022³
Accustem Sciences Inc.Board member Dec 3, 2021 to Dec 3, 2021⁴
Hepion Pharmaceuticals, Inc.Board member Oct 7, 2013 to May 20, 2021⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

OKYO Pharma Ltd OKYO35,201 shares⁶$49.3K at $1.40Jul 21, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 21, 2026Bought 5,000 shares at $1.48 of OKYO Pharma Ltd⁶
Jul 21, 2026Granted 5,000 shares at $1.48 of OKYO Pharma Ltd⁷
Sep 15, 2023Bought 16,670 shares at $1.50 of OKYO Pharma Ltd⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROKYO Pharma Ltd, Board member
2
SEC EDGARHepion Pharmaceuticals, Inc., Chair
3
SEC EDGARCardiff Oncology, Inc., Board member
4
SEC EDGARAccustem Sciences Inc., Board member
5
SEC EDGARHepion Pharmaceuticals, Inc., Board member
6
SEC EDGAROKYO Pharma Ltd shares after the filing of Jul 21, 2026
7
SEC EDGARForm 4 filed Jul 23, 2026
8
SEC EDGARForm 4 filed Sep 28, 2023